Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Clariant    CLN   CH0012142631

CLARIANT (CLN)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Clariant : Introduces Tri-Sorb® Desiccant Tablets for USP Moisture Testing of Blister...

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/05/2017 | 07:10am CEST
  • New source for important testing component
  • Smaller package quantities ideal for testing applications
  • Tablet experts to appear at industry tradeshows

Muttenz, October 5, 2017 - Clariant, a world leader in Specialty Chemicals, with its Healthcare Packaging business unit, is introducing Tri-Sorb molecular sieve desiccant tablets specifically designed for USP moisture permeability testing at several upcoming industry events.

The new tablets have been developed for pharmaceutical and nutraceutical packagers who are conducting moisture-permeation testing of unit-dose blister packaging as prescribed in USP . The Tri-Sorb tablets are designed for placement into blister headspaces, either singly or in multiples, in lieu of the actual drug product, where they are used to test and verify the moisture vapor transmission rate, or MTVR, of blister packaging according to the USP standard.

The tablets are packaged in quantities suitable for laboratory testing applications, with 320-350 tablets, depending on tablet size, in each re-sealable barrier pouch. To ensure product integrity and moisture adsorbtion capacity, Tri-Sorb desiccant tablets are not repackaged by a third party, but packaged directly on-site as part of the manufacturing process.

'Pharmaceutical manufacturers depend heavily on the results of USP testing to ensure that their drug packaging consistently achieves its specified MVTR,' says Audrey Pouliquen, Product Manager, Clariant Healthcare Packaging. 'Clariant has developed this line of desiccant tablets to specifically meet the requirements for this essential test.'

Tri-Sorb tablets are made from 4A molecular sieve and are available in three sizes: 0.125g, 0.25g and 0.37g. Similar Tri-Sorb tablets are also widely used in the packaging of medical devices and rapid diagnostic tests, where they protect functionality, accuracy, and shelf life from being compromised by moisture.

Complete product performance information and samples are available by contacting Clariant at healthpack.clariant.com. Product experts will be available to discuss the newly launched tablets at the following upcoming pharmaceutical and nutraceutical industry events:

  • CPHI Worldwide - Messe Frankfurt, Frankfurt, Germany, October 24-26, Booth 42L20 (www.cphi.com).
  • American Association of Pharmaceutical Scientists (AAPS) - San Diego Convention Center, San Diego, CA USA, November 13-15, Booth 1549, (www.aaps.org/annualmeeting).

Tri-Sorb® IS A TRADEMARK OF CLARIANT REGISTERED IN MANY COUNTRIES.

Clariant AG published this content on 05 October 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 05 October 2017 05:09:03 UTC.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CLARIANT
10/20 CLARIANT : launches Telasperse™ PVC pigment preparations for plasticized a..
10/20 CLARIANT : Healthcare packaging moisture-control solutions displayed at CPhI...
10/19 CLARIANT : unveils new amide/amine-free anti-stat and new moisture-control...
10/18 CLARIANT : launches product innovations & trend concept at SEPAWA 2017
10/17 CLARIANT : dedicated to promoting industry innovation at 18th Chinese National....
10/12 CLARIANT : features full color ranges for design and industry trends plus...
10/12 CLARIANT : introduces new combo of packaging solutions to protect shelf life of ..
10/12 CLARIANT : new sunflower-based surfactant is a true pioneer
10/10 CLARIANT : Packaging Solutions Extend Shelf Life of Oxygen- and Moisture-Sensiti..
10/10 CLARIANT : focuses on keeping winter air passengers flying high at inter airport..
More news
News from SeekingAlpha
10/06 Huntsman slides further as Clariant deal doubts rise
09/27 Clariant's Activist Shareholders Get Under Huntsman's Skin
09/19 Activist investor threatens to scuttle Huntsman-Clariant merger deal
09/04 CHEMICALS AND HURRICANE HARVEY : A Bad Formula
08/15 Clariant updates on Huntsman deal, says FTC made second info request
Financials ( CHF)
Sales 2017 6 253 M
EBIT 2017 655 M
Net income 2017 344 M
Debt 2017 1 597 M
Yield 2017 1,98%
P/E ratio 2017 24,34
P/E ratio 2018 20,69
EV / Sales 2017 1,56x
EV / Sales 2018 1,50x
Capitalization 8 142 M
Chart CLARIANT
Duration : Period :
Clariant Technical Analysis Chart | CLN | CH0012142631 | 4-Traders
Technical analysis trends CLARIANT
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Average target price 23,4  CHF
Spread / Average Target -4,7%
EPS Revisions
Managers
NameTitle
Hariolf Kottmann Chief Executive Officer & Executive Director
Rudolf Wehrli Chairman
Patrick Jany Chief Financial Officer
Peter Chen Non-Executive Director
Carlo G. Soave Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
CLARIANT39.33%8 269
ECOLAB INC.12.35%38 430
SIKA45.85%15 632
SYMRISE12.57%9 924
JOHNSON MATTHEY PLC6.73%8 765
INDORAMA VENTURES PCL--.--%7 039